Keep otitis externa treatment in safe hands

OTITIS EXTERNA (OE) AFFECTS 1 IN 5 DOGS
IN THEIR LIFETIME 1



The pain of OE and stress of at-home treatments can affect the quality of life of dogs and their owners.
It can:2,3


  • Affect dogs’ sleep and playing behaviours
  • Lead to physical and emotional disturbances in owners
  • Impair dog-owner relationships

What do vets recommend and pet owners prefer?

73%
Over Half
76%
99%

Neptra, the only 1-dose treatment for OE with Florfenicol that is administered by vets in clinic, guaranteeing 100% compliance.

SOLVE EVERYDAY OE TREATMENT WITH JUST ONE DOSE

Packshot Green Background



Early, effective vet-administered treatment can be key to successful outcomes. Neptra, administered in clinic, provides a full course of treatment in just one dose!




Avoid the uncertainty and ongoing stress of repeat at-home treatment with Neptra


  • The first ONE-dose treatment for OE
  • Vet-administered to guarantee 100% compliance
  • Flexible recheck to suit you, the patient and the owner

THE ONLY 1-DOSE TREATMENT WITH FLORFENICOL – WHEN INDICATED, FLORFENICOL IS A 1ST-LINE ANTIBIOTIC; SEE THE PROTECT ME GUIDELINES*6

Neptra offers a combination of 3 active ingredients that work together against the most common pathogens associated with OE.

Anti-inflammatory

Mometasone furoate

  • A potent, fast-acting steroid
  • Starts relieving pain and inflammation in just 30 minutes‡5
  • Antibiotic

    Florfenicol

  • When indicated, Florfenicol is a first line antibiotic; see the PROTECT ME guidelines*6
  • Anti-fungal

    Terbinafine hydrochloride

  • Provides potent anti-fungal activity
  • Highly effective against M. pachydermatis, a common fungal pathogen associated with otitis externa

  • Neptra targets the most common bacteria in OE, so you can:

    Reserve broader spectrum antibiotics for complex cases7

    Avoid "leftover" antibiotics lingering in owners' homes

    Keep OE treatment in safe hands

    GIVE DOGS RELIEF FROM THE PAIN AND DISCOMFORT OF EVERYDAY OE 5,8

    With its unique combination of active ingredients, Neptra's 1-dose solution:

    • Effectively treats up to 94% of routine canine OE cases**8
    • Is licensed for the treatment of the most common pathogens of OE cases (Staphylococcus pseudintermedius and Malassezia pachydermatis)
    • Provides lasting efficacy after one application, with continuous clinical improvement until day 289


    For pets

    Neptra treats the pain and inflammation of OE effectively, offering relief without multiple treatments.


    For owners

    Neptra can relieve stress and help protect the bond they have with their pets.


    For you

    Neptra can give you confidence that the job has been done, effectively, there and then.


    Provide much needed relief, by keeping OE treatment in safe hands with Neptra.

    Download Resources

    Get the full details, videos and resources by logging into MyElanco.

    Not registered yet? Don't miss out, see the benefits of MyElanco.

    HEAR FROM THE EXPERTS

    *for otitis associated with cocci; topical antibiotics may not always be required.6
    Tmax reached in 30 minutes. Neptra Summary of Product Characteristics 2023.
    **otitis associated with Staphylococcus pseudintermedius.8

    References

    1. 1. Paterson S et al. Companion Animal 2021 26:Sup3, S1-S16
    2. 2. Jamet J-F, et al. Prospective study of the effect of otitis externa before and after treatment on 20 owners’ assessment of their and their dog’s quality of life. Vet Dermatol 2016;27:45 (abstract).
    3. 3. Noli C, et al. Impact of a terbinafine-florfenicol-betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners. Vet Dermatol 2017;28:386–e90.
    4. 4. Dog Owner Compliance Evaluation, June 2019, n=2000 dog owners from FR/IT/ES/DE/NL/BE/UK/AU.
    5. 5. Neptra Summary of Product Characteristics 2023.
    6. 6. BSAVA/SAMSoc ‘Antibiotic Use in Our Practice’ poster 2023’ bsavalibrary.com/protectmeposter.
    7. 7. Barnard et al 2017. In Practice 39: 386-398.
    8. 8. Lynch SA, Helbig KJ. The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next? Vet Sci 2021;8:11.
    9. 9. Fitzgerald R. Proceedings of the British Veterinary Dermatology Spring Meeting 2021 73.
    10. 10. Elanco Neptra Marketing Research May 2022.

    Neptra POM-V (UK) and POM (Ireland) contains 16.7 mg florfenicol, 16.7 mg terbinafine hydrochloride, equivalent to terbinafine base: 14.9 mg, and 2.2 mg mometasone furoate.


    Further information is available from the SPC, datasheet or pack leaflet. Advice should be sought from the Medicine Prescriber. Contact Elanco Animal Health for further information on 01256 353131 or email elancouk@elanco.com, or write to: Elanco Animal Health, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA.


    Neptra, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.


    © 2024 Elanco or its affiliates. PM-IE-23-0089. Date of preparation: 02/24.


    Use medicines responsibly www.noah.co.uk/responsible, www.apha.ie.